Observational study / 2019
Higher admission plasma TMAO levels were linked to increased risks of poor functional outcome and mortality at 3 months in acute ischemic stroke patients.
Researchers prospectively recruited 225 acute ischemic stroke patients to examine the link between admission plasma TMAO levels and 3-month outcomes. At 3 months, 116 patients (51.6%) had a poor functional outcome and 51 patients (22.7%) had died. After adjusting for potential confounders, patients in the highest TMAO quartile had higher risks of poor functional outcome (OR 3.63; 95% CI 1.34-9.82; P = 0.011) and mortality (OR 4.27; 95% CI 1.07-17.07; P = 0.040) compared with the lowest quartile.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 225 acute ischemic stroke patients diagnosed within 24 hours of symptom onset
- What was measured
- Poor functional outcome (mRS 3-6) and mortality at 3 months
THE PAPER
Prognostic Value of Plasma Trimethylamine N-Oxide Levels in Patients with Acute Ischemic Stroke.
Zhai Q, Wang X, Chen C, Tang Y, Wang Y, Tian J, Zhao Y, Liu X. Cell Mol Neurobiol, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.